CURE Pharmaceutical to Present at Two Virtual Events in September

- CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT - 

- CURE CEO will be a panelist at the 4@4 Forum on September 10 @4pm PDT -

OXNARD, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at two upcoming virtual conferences in September.

• The LD 500 Virtual Conference on Friday, September 4 at 8:20amPDT/11:20pm EDT
  
  Rob Davidson, President and CEO of CURE Pharmaceutical will present to a live virtual audience at the LD 500 investor conference on Friday, September 4 at 8:20am PDT. The LD 500 will take place on September 1-4. Register here: 
  
  The full conference profile for CURE Pharmaceutical Holdings can be viewed here: .

• Four At Four Forum on September 10 @ 4pm PDT
  
  Rob Davidson will be joined by Nancy Duitch, CEO of Sera Labs as featured panelists at the Virtual 4@4 Forum on September 10 at 4pm PDT. The topic for the event is “CBD, Cannabis and the Cannabiz”. Registration is free but is required in advance at: CURE . Sera Labs is a trusted leader in the health, wellness and beauty sectors of CBD and creates high quality products that use science-backed, proprietary formulations and organic hemp. Brand names include: SeraRelief™, SeraTopical™, SeraLabs™, Gordon’s Herbals™ and SeraPets™.

About CURE Pharmaceutical Holding Corp.

CURE Pharmaceutical^® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.

CURE’s delivery vehicles include ^®, an advanced oral thin film; , a novel chewable liquid or solid delivery form; and , an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others.

CURE’s proprietary clinical pipeline includes (sildenafil to treat erectile dysfunction), and (THC and CBD). Other OTC wellness products include Vitamin D, BCP Sleep, and Electrolytes. (Visit for the complete list.) As a vertically integrated company, CURE’s 25,000 square foot, FDA-registered, NSF^® and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.